Risk Factors for Seizures in Very Low Birthweight Infants With Periventricular Leukomalacia

Abstract

This population-based observational study aimed to determine the perinatal factors that were associated with the occurrence of seizures in very low birthweight infants with periventricular leukomalacia. The study sample consisted of 545 infants from the Israel National Very Low Birthweight Infant Database, gestational age 24 to 36 weeks, who survived beyond 28 days of age, in whom a late cranial ultrasonographic examination was performed and in whom periventricular leukomalacia was diagnosed. To evaluate the association between periventricular leukomalacia and confounding variables on the occurrence of seizures, the chi-square test, univariate analysis, and a logistic regression model were used. Of the 545 infants who developed periventricular leukomalacia, 102 (18.7%) had seizures. Significant independent predictors of seizures among these infants were decreasing gestational age, intraventricular hemorrhage, posthemorrhagic hydrocephalus, sepsis, and necrotizing enterocolitis. Infants with both sepsis and necrotizing enterocolitis had a 4.6-fold increased risk of seizures, further suggesting a possible role of infection in the pathogenesis of brain injury in preterm infants. (J Child Neurol 2006;21:965—970; DOI 10.2310/7010.2006.00226).

Get full access to this article

View all access options for this article.

References

Perlman JM , Risser R. , Broyles RS : Bilateral cystic periventricular leukomalacia in the premature infant: Associated risk factors. Pediatrics 1996;97:822—827.

Zupan V. , Gonzalez P. , Lacaze-Masmonteil T. , et al: Periventricular leukomalacia: Risk factors revised. Dev Med Child Neurol 1996; 38:1061—1067.

Yoon BH , Jun JK , Romero R. , et al: Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor α), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997;177:19—26.

Volpe JJ : Neurology of the Newborn. 4th ed. Philadelphia, WB Saunders, 2001.

Kohelet D. , Shochat R. , Lusky A. , Reichman B. : Israel Neonatal Network. Risk factors for neonatal seizures in very low birthweight infants: population-based survey. J Child Neurol 2004;19:123—128.

Okumura A. , Hayakawa F. , Kato T. , et al: Abnormal sharp transients on electroencephalograms in preterm infants with periventricular leukomalacia. J Pediatr 2003;143:26—30.

Gurses C. , Gross DW , Andermann F. , et al: Periventricular leukomalacia and epilepsy: Incidence and seizure pattern. Neurology 1999;52:341—345.

Vermont Oxford Network Database Manual of Operations, Release 2.0. Burlington, VT, Vermont Oxford Network, 1993.

Stoll BJ , Hansen NI , Adams-Chapman I. , et al: Neuro-developmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004 ;292: 2357—2365.

10.

Romagnoli C. , Frezza S. , Cingolani A. , et al: Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis. Eur J Pediatr 2001; 160:345-350.

11.

Edelson MB , Bagwell CE , Rozycki HJ : Circulation pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999;103:766—771.

12.

Hotchkiss RS , Karl IE : The pathophysiology and treatment of sepsis . N Engl J Med 2003;348:138—150.

13.

Blattels CM : In Interleukin-1 in the Brain, in Rothwell NJ , Dantzer R (eds). Amsterdam, Elsevler Science Pub. Co. 1992, 135—138.

14.

Gutierrez EG , Banks WA , Kastin AJ : Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 1993;47:169—176.

15.

De Vries HE , Kuiper J. , de Boer AG , et al: The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev 1997;49:143—155.

16.

Westmoreland SV , Kolson D. , Gonzalez-Scarano F. : Toxicity of TNF-α and platelet activating factor for human NT2N neurons: A tissue culture model for human immunodeficiency virus dementia. JNeurovirol 1996;2:118-126.

17.

Selmaj KW , Raine CS : Tumor necrosis factor mediated myelin and oligodendrocytes damage in vitro . Ann Neurol 1988;23:339— 436.

18.

Yoon BH , Romero R. , Kim CJ , et al: High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol 1997;177:406—411.

19.

Dommergues MA , Patkai J. , Renauld JC , et al: Proinflammatory cytokines and interleukin-9 exacerbate excitoxic lesions of the newborn murine neopallium. Ann Neurol 2000;47:54—63.

20.

Yuhas Y. , Shulman L. , Weizman A. , et al: Involvement of tumor necrosis factor alpha and interleukin-1β in enhancement of pentylenetetrezol-induced seizures caused by Shigella dysenteriae . Infect Immunol 1999;67:1455—1460.

21.

Bellinger FP , Madamba S. , Siggins GR : Interleukin 1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res 1993;628:227—234.

22.

Jankowsky JL , Patterson PH : Cytokine and growth factor involvement in long-term potentiation. Mol Cell Neurosci 2000; 14:529—543.

23.

Fields RD , Stevens-Graham B. : New insights into neuron-glia communication. Science 2002;298:556—562.

24.

Kuban S. , Sanocka U. , Leviton A. , et al: White matter disorder of prematurity: Association with intraventricular hemorrhage and ventriculomegaly. J Pediatr 1999;134:539—546.

25.

Strober JB , Bienkowski RS , Maytal J. : The incidence of acute and remote seizures in children with intraventricular hemorrhage. Clin Pediatr (Phila) 1997;36:643—647.